SCHEMBL3580343

SCHEMBL3580343

Nc1cccc2oc(C(=O)O)cc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 5/20 0.59
CSNK2A2 P19784 4/20 0.59
CSNK2B P67870 4/20 0.59
CSNK2A3 Q8NEV1 4/20 0.59
KDM4E B2RXH2 2/20 0.59
USP2 O75604 1/20 0.59
PTGS1 P23219 1/20 0.59
PIM1 P11309 5/20 0.56
TDP1 Q9NUW8 2/20 0.56
MAPT P10636 2/20 0.56
GLA P06280 1/20 0.56
HPGD P15428 1/20 0.56
TSHR P16473 1/20 0.56
HTT P42858 1/20 0.56
HSD17B10 Q99714 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
GPR35 Q9HC97 3/20 0.47
ALDH1A1 P00352 1/20 0.46
TBK1 Q9UHD2 1/20 0.45
AKR1B1 P15121 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27512419 0.81 CSNK2A1 (0.59) CSNK2A1CSNK2A2CSNK2BCSNK2A3KDM4E
Methane SCHEMBL27891504 0.80 CSNK2A1 (0.57) CSNK2A1CSNK2A2CSNK2BCSNK2A3KDM4E
SCHEMBL27512420 0.80 CSNK2A1 (0.57) CSNK2A1CSNK2A2CSNK2BCSNK2A3KDM4E
SCHEMBL27608547 0.80 CSNK2A1 (0.57) CSNK2A1CSNK2A2CSNK2BCSNK2A3KDM4E
SCHEMBL1887268 0.80 CSNK2A1 (0.57) CSNK2A1CSNK2A2CSNK2BCSNK2A3KDM4E
SCHEMBL1893419 0.80 MCL1 (0.58) CSNK2A1CSNK2A2CSNK2BCSNK2A3KDM4E
SCHEMBL31353110 0.80 CSNK2A1 (0.57) CSNK2A1CSNK2A2CSNK2BCSNK2A3KDM4E
SCHEMBL8440444 0.80 CSNK2A1 (0.57) CSNK2A1CSNK2A2CSNK2BCSNK2A3KDM4E
SCHEMBL29865935 0.80 CSNK2A1 (0.57) CSNK2A1CSNK2A2CSNK2BCSNK2A3KDM4E
SCHEMBL27878925 0.80 KDM4E (0.53) KDM4ETDP1MAPTHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7834010-B2 Modulators of peripheral 5-HT receptors SERODUS AS (NO) 2010-11-16 US disclosed
US-20070254874-A1 Modulators of Preripheral 5-Ht Receptors BIO-MEDISINSK INNOVASJON (NO) 2007-11-01 US disclosed
EP-1701951-A2 MODULATORS OF PERIPHERAL 5-HT RECEPTORS Bio-Medisinsk Innovasjon AS (NO) 2006-09-20 EP disclosed
WO-2005061483-A2 MODULATORS OF PERIPHERAL 5-HT RECEPTORS BIO-MEDISINSK INNOVASJON AS (NO) 2005-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254874-A1 Modulators of Preripheral 5-Ht Receptors HTR4, HTR5A, HTR6 CSNK2A1 3492/4885CSNK2A2 3466/4885CSNK2B 3087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.